GLYCOMIRA, LLC
Transforming Cancer Therapy
SALT LAKE CITY, United States · Founded 2016
- Headquarters
- SALT LAKE CITY, Utah
- Founded
- 2016
- Business Model
- B2G
- Website
- glycomira.com
- Last Round
- Grant
About
GlycoMira Therapeutics is a clinical-stage biopharmaceutical company developing innate immune system modulators based on polysaccharides that naturally occur in the body. Their lead drug candidate, GM-1111, targets unmet needs in solid tumor treatment, radiation-induced injuries such as Oral Mucositis and Acute Radiation Syndrome, and chronic rhinosinusitis. The company's R&D is funded through NIH awards and private investment.
Summary
GLYCOMIRA, LLC is a Biotech company based in SALT LAKE CITY, United States, founded in 2016.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.